Swedbank AB grew its holdings in shares of Humana Inc. (NYSE:HUM – Free Report) by 6.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 111,803 shares of the insurance provider’s stock after purchasing an additional 6,534 shares during the period. Swedbank AB owned approximately 0.09% of Humana worth $28,636,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of the company. Montag A & Associates Inc. grew its stake in Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares in the last quarter. CoreCap Advisors LLC grew its stake in Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares in the last quarter. Rosenberg Matthew Hamilton grew its stake in Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares in the last quarter. Larson Financial Group LLC grew its stake in Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after acquiring an additional 81 shares in the last quarter. Finally, Fulcrum Asset Management LLP purchased a new position in Humana during the 3rd quarter valued at about $42,000. 92.38% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
HUM has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft cut Humana from a “buy” rating to a “hold” rating in a research note on Wednesday. UBS Group boosted their target price on Humana from $262.00 to $320.00 and gave the stock a “neutral” rating in a report on Friday. Needham & Company LLC assumed coverage on Humana in a report on Wednesday. They issued a “buy” rating for the company. Leerink Partners upped their price target on Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a report on Thursday, April 30th. Finally, Zacks Research upgraded Humana from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 13th. Nine equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $263.35.
Humana Stock Performance
HUM opened at $307.79 on Monday. The stock has a market cap of $36.95 billion, a PE ratio of 32.92, a P/E/G ratio of 2.86 and a beta of 0.68. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $315.66. The stock’s 50 day simple moving average is $218.13 and its 200-day simple moving average is $227.27.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.Humana’s quarterly revenue was up 23.5% on a year-over-year basis. During the same period in the previous year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts forecast that Humana Inc. will post 9.01 EPS for the current year.
Humana Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. Humana’s payout ratio is currently 37.86%.
Humana Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
